Evidence continues to suggest that patients with cancer require more information about their disease and its consequences. To evaluate the information needs of patients with advanced melanoma compared to patients with other malignancies, a cross-sectional study was conducted on 221 unselected...

Growing up, I would use baby oil and iodine and lay out in the sun to get a good tan. And my daughter did what her friends were doing and got a tan at a tanning salon before the prom. Now it is hard to drive by a group of stores without seeing a tanning salon. In the past 30 years, we have seen the...

Treatment-related dermatologic toxicities are common for patients with cancer. Rashes associated with dermatologic toxicities are best treated by a physician who specializes in dermatologic conditions resulting from cancer treatment, but scheduling and travel may present challenges for patients...

Ipilimumab is a U.S. Food and Drug Administration-approved novel T-cell potentiator that improves survival in metastatic melanoma. Ipilimumab blocks cytotoxic T-lymphocyte antigen-4, a negative regulator of the immune response, thus promoting T-cell activation and prolonging a patient's antitumor...